drugset / Trial / NCT03264651
Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the impact of a selective androgen receptor modulator combined with an aromatase inhibitor in reducing high mammographic breast density.
Timeline
- Start
- 2017-02-01
- Primary completion
- 2018-03-21
- Completion
- 2018-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anastrozole | Other / unclassified | 1 mg | Oral |
| Subject | Enobosarm | Small molecule | 9 mg | Oral |